cancer recurrence (Deimos Study): A study of the Palliative Care Working

Autor: Alkan, A, Yasar, A, Guc, ZG, Gurbuz, M, Basoglu, T, Goksu, SS, Basal, FB, Turk, HM, Ozdemir, O, Cinkir, HY, Guven, DC, Kus, T, Turker, S, Koral, L, Karakas, Y, Ak, N, Paydas, S, Karci, E, Demiray, AG, Demir, A, Alan, O, Keskin, O, Nayir, E, Tanriverdi, O, Yavuzsen, T, Yumuk, PF, Ates, O, Coskun, HS, Turhal, S, Senler, FC

Objective Fear of cancer recurrence (FCR) is an important psychological trauma associated with reduction in the quality of life, disruptions in the level of adjustment, emotional distress and anxiety. The purpose of the study was to evaluate the impa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3566::0435eb35bc6223167400964b7b4fbf93

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma.

Autor: Sencan O, Buyukcelik A, Yalcin B, Boruban MC, Akbulut H, Demirkazik A, Senler FC, Onur H, Icli F

Publikováno v: European Journal of Cancer Care; Jan2008, Vol. 17 Issue 1, p26-32, 7p

Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG).

Autor: Akyildiz A; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey. drakyildizarif@gmail.com., Guven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Koksal B; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Karaoglan BB; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Kivrak D; Department of Medical Oncology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey., Ismayilov R; Department of Internal Medicine, Hacettepe University Medical School, Ankara, Turkey., Aslan F; Department of Medical Oncology, Ankara Medical Park Hospital, Ankara, Turkey., Sutcuoglu O; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey., Yazici O; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey., Kadioglu A; Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Alan O; Department of Medical Oncology, Koç University, Istanbul, Turkey., Majidova N; Department of Medical Oncology, Marmara University, Pendik Training and Research Hospital, Istanbul, Turkey., Erciyestepe M; Department of Medical Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey., Ozcan E; Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey., Akdag G; Department of Medical Oncology, University of Health Science, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey., Taban H; Department of Medical Oncology, Samsun Training and Research Hospital, Samsun, Turkey., Kaya AO; Department of Medical Oncology, Biruni University Faculty of Medicine, Istanbul, Turkey., Guliyev M; Department of Medical Oncology, Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey., Yildirim N; Department of Medical Oncology, Firat University Faculty of Medicine, Elazig, Turkey., Sakalar T; Department of Medical Oncology, Necip Fazil City Hospital, Kahramanmaras, Turkey., Yazilitas D; Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey., Unal C; Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey., On S; Department of Oncology, Ege University Faculty of Medicine, Izmir, Turkey., Biter S; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Demirci NS; Department of Medical Oncology, Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey., Senler FC; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Kemal Y; Department of Medical Oncology, Altinbas University Faculty of Medicine, Samsun, Turkey., Halil OD; Department of Medical Oncology, Near East University Hospital, Nicosia, Cyprus., Gullu I; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

Publikováno v: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2024 Sep; Vol. 281 (9), pp. 4991-4999. Date of Electronic Publication: 2024 May 25.

Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer.

Autor: Yazici O; Department of Medical Oncology, Gazi University School of Medicine, Besevler/Ankara,Turkey., Dogan M; Department of Medical Oncology, Ankara Numune Hospital, Ankara,Turkey., Ozal G; Department of Medical Oncology, Bayindir Hospital, Ankara,Turkey., Aktas SH; Eskisehir Osmangazi University Vocational Scholl of Health Services, Eskisehir,Turkey., Demirkazik A; Department of Medical Oncology, Bayindir Hospital, Ankara,Turkey., Utkan G; Department of Medical Oncology, Ankara University School of Medicine, Ankara,Turkey., Senler FC; Department of Medical Oncology, Ankara University School of Medicine, Ankara,Turkey., Icli F; Department of Medical Oncology, Ufuk University, Ankara,Turkey., Akbulut H; Department of Medical Oncology, Ankara University School of Medicine, Ankara,Turkey.

Publikováno v: Combinatorial chemistry & high throughput screening [Comb Chem High Throughput Screen] 2021; Vol. 24 (8), pp. 1229-1235.